The who has objected to the excessive dose of hydroxychloroquine imposed ban on the trial of hydroxychloroquine drug, which is considered to be very effective in the treatment of the ban corona, which is being given four times more doses of hydroxychloroquine drug abroad. The Indian Council of Medical Research (ICMR) has written to who said that the drug is not being properly trial at the international level. So that the results are coming apart. According to the health ministry, there is a big difference between the trial of Hydroxychloroquine in India and internationally. At present, India has set a protocol to give hydroxychloroquine drugs. According to which a heavy dose of 400 mg is being given to the patient on the first day in the morning and evening. The dose of 200 mg can be given in the morning and evening for the next four days.
The patient is taking a total dose of 2400 mg in 5 days. While two doses of 800 mg are given internationally on the first day and then two doses of 400 mg are given for the next 10 days. In this way, the patient takes a total dose of 9600 mg in 11 days. Which is 4 times more than That of India. India has filed its complaint with the WHO in the matter stating that all the reports have not been carefully looked into before the trial of hydroxychloroquine is temporarily postponed. When a small dose is being given, the patient’s recovery is intensifying, while giving more doses is a natural side effect. Tell us that a few days ago, a health magazine called The Last said that it had made research on about 15,000 corona patients. The drug has not had any significant effect on the hydroxychloroquine drug. Rather, its use has increased the mortality rate of corona-infected. Thereafter, on May 25, the WHO banned its trial.